Moreover, the frequencies of CCND1 amplification and CDKN2A deletion in T1 ESCC areas were significantly higher than those in non-cancerous areas (p < 0.001 for both) (Supplementary Figure 4C). This evidence concerns the gene CCND1 and esophageal squamous cell carcinoma.